GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 14 Oct 2019, 06:16

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

The decline in the price of biotech stocks has hurt many institutions

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Find Similar Topics 
Senior RC Moderator
User avatar
V
Joined: 02 Nov 2016
Posts: 4069
GPA: 3.39
The decline in the price of biotech stocks has hurt many institutions  [#permalink]

Show Tags

New post 20 Mar 2019, 07:47
00:00
A
B
C
D
E

Difficulty:

  15% (low)

Question Stats:

82% (01:40) correct 18% (02:22) wrong based on 101 sessions

HideShow timer Statistics

The decline in the price of biotech stocks has hurt many institutions that had invested heavily in biotech companies. Last year the state university added 200,000 shares of a biotech stock to its holdings. The stock in question has declined in value by more than 90 percent over the last 12 months. The college, however, did not purchase the stock, but received it as a gift. Therefore, the price decline will not harm the university’s finances.

Which of the following, if true, casts the most doubt on the conclusion that the price decline of biotech stocks will not harm the university’s finances?

A. The biotech sector is volatile; some stocks that lose 90 percent of their value in one year may regain all of their value and more in the following year.

B. The university needs to pay capital gains taxes only on a stock sale that results in a gain; stocks sold at a loss will incur no tax penalty.

C. Although the biotech sector is down, the overall health-care sector, in which the university has invested heavily, is up for the year.

D. The biotech company in question has a promising new drug in development that could revolutionize the treatment of type II diabetes.

E. The university began construction of a new laboratory last year that the provost had expected to pay for with the proceeds from the sale of the biotech stock in question.

Source: McGraw Hill's GMAT (5th)
Difficulty Level: 650

_________________
Manager
Manager
avatar
S
Joined: 04 Sep 2016
Posts: 66
Location: Germany
GPA: 3
CAT Tests
Re: The decline in the price of biotech stocks has hurt many institutions  [#permalink]

Show Tags

New post 09 Apr 2019, 06:02
The answer is E because it weakens the conclusion that the decline in price of stock wont affect them.

The college was banking on paying for the construction from the profits of the stock. But since now no profits are there it will impact them.

A - conditional statement..may or may not happen
B - sort of Strenghtens
C - irrelevant/ out of scope
D - irrelevant/ out of scope

Posted from my mobile device
_________________
Proud Wildling :)


Your Kudos are much appreciated


The three great essentials to achieve anything worthwhile are, first, hard work; second, stick-to-itiveness; third, common sense."
GMAT Club Bot
Re: The decline in the price of biotech stocks has hurt many institutions   [#permalink] 09 Apr 2019, 06:02
Display posts from previous: Sort by

The decline in the price of biotech stocks has hurt many institutions

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  





Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne